packageResminostat

resminostat

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Resminostat is an investigational anticancer drug, a histone deacetylase inhibitor studied for treating cutaneous T-cell lymphomas such as mycosis fungoides and Sézary syndrome. It is not an approved medicine; in the European Union it has only reached the opinion stage of regulatory assessment.

Summary written by glm-5.3-flash from Wikidata Q18394103 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:resminostat
ATC codes:L01XH07
DrugBank:DB12392
PubChem CID:11609955
Wikidata:Q18394103
formula:C16H19N3O4S
molar mass:349.405 g/mol (PubChem CID 11609955)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown